Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fournet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature|March 19, 2010
Correction of measurements of low-angle X-ray scatteringA GUINIER, G FOURNET
Annales De L'Anesthesiologie Francaise|January 1, 1981
[Transfusional malaria. Apropros of a case in Limousin]G Fournet, J M Filloux
Current Medicinal Chemistry|December 13, 2012
α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosisG Fournet, G Martin, G Quash
Perceptual and Motor Skills|December 1, 1989
Response to KirtonE Robertson, G Fournet, P Zelhart, et al.
FEBS Letters|November 20, 1995
Dose-dependent activation and block by bisG10, a K+ channel blocker, of mouse and frog skeletal muscle KATP channelsB Allard, G Fournet, O Rougier, et al.
The Biochemical Journal|February 1, 1995
Methional derived from 4-methylthio-2-oxobutanoate is a cellular mediator of apoptosis in BAF3 lymphoid cellsG Quash, A M Roch, J Chantepie, et al.
Advances in Experimental Medicine and Biology|June 3, 1999
A thioester analogue of an amino acetylenic aldehyde is a suicide inhibitor of aldehyde dehydrogenase and an inducer of apoptosis in mouse lymphoid cells overexpressing the bcl2 geneG Quash, G Fournet, C Raffin, et al.
Chemico-Biological Interactions|April 18, 2001
The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and deathR A Canuto, G Muzio, R A Salvo, et al.
Current Medicinal Chemistry|April 10, 2009
Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administrationE Hiltbrand, G Fournet, J-P Giliberto, et al.
Blood Cancer Journal|September 10, 2016
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitorsG Venton, M Pérez-Alea, C Baier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature|March 19, 2010
Correction of measurements of low-angle X-ray scatteringA GUINIER, G FOURNET
Annales De L'Anesthesiologie Francaise|January 1, 1981
[Transfusional malaria. Apropros of a case in Limousin]G Fournet, J M Filloux
Current Medicinal Chemistry|December 13, 2012
α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosisG Fournet, G Martin, G Quash
Perceptual and Motor Skills|December 1, 1989
Response to KirtonE Robertson, G Fournet, P Zelhart, et al.
FEBS Letters|November 20, 1995
Dose-dependent activation and block by bisG10, a K+ channel blocker, of mouse and frog skeletal muscle KATP channelsB Allard, G Fournet, O Rougier, et al.
The Biochemical Journal|February 1, 1995
Methional derived from 4-methylthio-2-oxobutanoate is a cellular mediator of apoptosis in BAF3 lymphoid cellsG Quash, A M Roch, J Chantepie, et al.
Advances in Experimental Medicine and Biology|June 3, 1999
A thioester analogue of an amino acetylenic aldehyde is a suicide inhibitor of aldehyde dehydrogenase and an inducer of apoptosis in mouse lymphoid cells overexpressing the bcl2 geneG Quash, G Fournet, C Raffin, et al.
Chemico-Biological Interactions|April 18, 2001
The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and deathR A Canuto, G Muzio, R A Salvo, et al.
Current Medicinal Chemistry|April 10, 2009
Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administrationE Hiltbrand, G Fournet, J-P Giliberto, et al.
Blood Cancer Journal|September 10, 2016
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitorsG Venton, M Pérez-Alea, C Baier, et al.
Pageof 2